In the News

Körber and Vineti Announce Partnership to Provide improved Manufacturing Performance and Visibility Globally for Cell and Gene-Based Therapies

Körber, a manufacturing execution systems supplier for pharma and biotech, has partnered with Vineti to integrate Körber’s Werum PAS-X-MES with Vineti’s Personalized Therapy Management (PTM) platform. The partnership will empower biopharma customers with an integrated PAS-X-MES and supply chain data management solution to bring life-saving...

Lightship Raises $40 Million to Bring Clinical Trials to Every Patient in Need

Lightship, a virtual-first provider of clinical trials, today announced that it has raised $40 million to create access to clinical research for all patients, and improve diversity among patient groups taking part in clinical trials around the world. The funding round was led by Define Ventures...

Transforming the Rare Disease Landscape with Data

AllStripes, formerly known as RDMD, recently completed a $50 million venture round, which it will use to launch 100 new rare disease research programs. Global Genes recently interviewed AllStripes Co-founder and CEO Nancy Yu about the growing efforts around patient data collection, where AllStripes fits...

AllStripes Announces Key Leadership Hires as Expansion and Growth Accelerate

AllStripes, a healthcare technology company dedicated to unlocking new treatments for people affected by rare diseases, has hired Sherwin Chen as chief legal officer and Joe Walsh as vice president and head of commercial. Chen is an experienced counsel specializing in advising high-growth digital health, biotech,...

With $1.3 billion in venture funding, the femtech space is booming

There’s been a lot of talk about “femtech” booming over the past several months. However, a new report by Rock Health shows that even though there’s been a lot of funding in the space so far this year, it still accounts for a tiny fraction...

NHS launches World’s Largest Trial of Cancer Blood Test

The National Health Service (NHS) in the United Kingdom has announced the world’s largest trial of GRAIL’s Galleri blood test, which was developed to detect more than 50 types of cancer before symptoms appear. The NHS hopes to recruit 140,000 volunteers across the UK to...